VEGFA and choroidal neovascularization: Intravitreal administration of anti-vascular endothelial growth factor (VEGF) compounds like Bevacizumab, Ranibizumab, and Aflibercept is the first-line treatment for neovascular AMD (mainly choroidal neovascularization (CNV)).